Phenotypic Variation in Vietnamese Osteogenesis Imperfecta Patients Sharing a Recessive


Journal

Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097

Informations de publication

Date de publication:
24 02 2022
Historique:
received: 19 01 2022
revised: 14 02 2022
accepted: 21 02 2022
entrez: 25 3 2022
pubmed: 26 3 2022
medline: 28 4 2022
Statut: epublish

Résumé

Osteogenesis imperfecta (OI) is a syndromic disorder of bone fragility with high variation in its clinical presentation. Equally variable is molecular aetiology; recessive forms are caused by approximately 20 different genes, many of which are directly implicated in collagen type I biosynthesis. Biallelic variants in prolyl 3-hydroxylase 1 (P3H1) are known to cause severe OI by affecting the competence of the prolyl 3-hydroxylation—cartilage associated protein—peptidyl-prolyl cis-trans isomerase B (P3H1-CRTAP-CyPB) complex, which acts on the Pro986 residue of collagen type I α 1 (COL1A1) and Pro707 collagen type I α 2 (COL1A2) chains. The investigation of an OI cohort of 146 patients in Vietnam identified 14 families with P3H1 variants. The c.1170+5G>C variant was found to be very prevalent (12/14) and accounted for 10.3% of the Vietnamese OI cohort. New P3H1 variants were also identified in this population. Interestingly, the c.1170+5G>C variants were found in families with the severe clinical Sillence types 2 and 3 but also the milder types 1 and 4. This is the first time that OI type 1 is reported in patients with P3H1 variants expanding the clinical spectrum. Patients with a homozygous c.1170+5G>C variant shared severe progressively deforming OI type 3: bowed long bones, deformities of ribcage, long phalanges and hands, bluish sclera, brachycephaly, and early intrauterine fractures. Although it remains unclear if the c.1170+5G>C variant constitutes a founder mutation in the Vietnamese population, its prevalence makes it valuable for the molecular diagnosis of OI in patients of the Kinh ethnicity. Our study provides insight into the clinical and genetic variation of P3H1-related OI in the Vietnamese population.

Identifiants

pubmed: 35327962
pii: genes13030407
doi: 10.3390/genes13030407
pmc: PMC8950175
pii:
doi:

Substances chimiques

Collagen Type I 0
Extracellular Matrix Proteins 0
Membrane Glycoproteins 0
Molecular Chaperones 0
Proteoglycans 0
Prolyl Hydroxylases EC 1.14.11.-
P3H1 protein, human EC 1.14.11.7

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

J Med Genet. 1991 Jul;28(7):433-42
pubmed: 1895312
Pediatr Dev Pathol. 2011 May-Jun;14(3):228-34
pubmed: 20946018
Am J Hum Genet. 2009 Oct;85(4):521-7
pubmed: 19781681
Hum Genomics. 2019 Jun 3;13(1):25
pubmed: 31159867
J Bone Miner Res. 2020 Dec;35(12):2381-2392
pubmed: 32722848
Annu Rev Biophys Biophys Chem. 1991;20:137-52
pubmed: 1867713
Mol Genet Genomic Med. 2018 Jan;6(1):15-26
pubmed: 29150909
Bone Rep. 2018 Sep 15;9:132-135
pubmed: 30246063
Eur J Med Genet. 2010 Jan-Feb;53(1):1-5
pubmed: 19878741
Genet Med. 2012 May;14(5):543-51
pubmed: 22281939
Nat Genet. 2007 Mar;39(3):359-65
pubmed: 17277775
Front Genet. 2020 Sep 15;11:984
pubmed: 33093841
Clin Transl Sci. 2020 Sep;13(5):960-971
pubmed: 32166892
Nucleic Acids Res. 1997 Jan 1;25(1):181-7
pubmed: 9016532
Mol Genet Genomic Med. 2013 Nov;1(4):194-205
pubmed: 24498616
Dis Model Mech. 2019 Jun 20;12(6):
pubmed: 31171565
Hum Mutat. 2011 May;32(5):557-63
pubmed: 21520333
Adv Clin Exp Med. 2021 Dec;30(12):1233-1238
pubmed: 34637196
J Med Genet. 1979 Apr;16(2):101-16
pubmed: 458828
Hum Genomics. 2016 Aug 12;10(1):27
pubmed: 27519266
Oral Surg Oral Med Oral Pathol Oral Radiol. 2021 Dec;132(6):e198-e207
pubmed: 33737016
J Bone Miner Res. 2013 Nov;28(11):2333-7
pubmed: 23674381
Int Orthop. 2017 Jan;41(1):21-29
pubmed: 27807717
Cell. 2006 Oct 20;127(2):291-304
pubmed: 17055431
Bone. 2018 May;110:368-377
pubmed: 29499418
Fetal Pediatr Pathol. 2013 Oct;32(5):319-25
pubmed: 23301918
Genes (Basel). 2022 Jan 10;13(1):
pubmed: 35052464
J Med Genet. 2009 Apr;46(4):233-41
pubmed: 19088120
J Bone Miner Metab. 2012 Jan;30(1):69-77
pubmed: 21667357
Am J Med Genet A. 2016 Dec;170(12):3150-3156
pubmed: 27576954
Bone. 2022 Feb;155:116293
pubmed: 34902613
PLoS One. 2012;7(5):e36809
pubmed: 22615817
Hum Genet. 2021 Aug;140(8):1121-1141
pubmed: 34169326
Hum Mutat. 2008 Dec;29(12):1435-42
pubmed: 18566967

Auteurs

Lidiia Zhytnik (L)

Department of Human Genetics, Amsterdam Movement Sciences, Amsterdam UMC, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
Department of Traumatology and Orthopaedics, Institute of Clinical Medicine, The University of Tartu, Puusepa 8, 50410 Tartu, Estonia.

Binh Ho Duy (BH)

Faculty of Nursing, College of Medicine and Pharmacy, Hue University, 06 Ngo Quyen, Hue 530000, Vietnam.

Marelise Eekhoff (M)

Amsterdam Bone Centre, Department of Internal Medicine Section Endocrinology, Amsterdam UMC, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.

Lisanne Wisse (L)

Department of Human Genetics, Amsterdam Movement Sciences, Amsterdam UMC, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.

Gerard Pals (G)

Department of Human Genetics, Amsterdam Movement Sciences, Amsterdam UMC, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.

Ene Reimann (E)

Institute of Genomics, The University of Tartu, Riia 23b, 51010 Tartu, Estonia.

Sulev Kõks (S)

QEII Medical Centre, Perron, Institute for Neurological and Translational Science, 8 Verdun Street, Nedlands, WA 6009, Australia.
Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, 90 South Street, Murdoch, Perth, WA 6150, Australia.

Aare Märtson (A)

Department of Traumatology and Orthopaedics, Institute of Clinical Medicine, The University of Tartu, Puusepa 8, 50410 Tartu, Estonia.
Clinic of Traumatology and Orthopaedics, Tartu University Hospital, Puusepa 8, 50410 Tartu, Estonia.

Alessandra Maugeri (A)

Department of Human Genetics, Amsterdam Movement Sciences, Amsterdam UMC, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.

Katre Maasalu (K)

Department of Traumatology and Orthopaedics, Institute of Clinical Medicine, The University of Tartu, Puusepa 8, 50410 Tartu, Estonia.
Clinic of Traumatology and Orthopaedics, Tartu University Hospital, Puusepa 8, 50410 Tartu, Estonia.

Dimitra Micha (D)

Department of Human Genetics, Amsterdam Movement Sciences, Amsterdam UMC, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH